Brighthouse Financial (BHF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
23 Dec, 2025Executive summary
A merger agreement was approved for the acquisition of the company by Aquarian Holdings VI L.P., with each outstanding common share to be converted into $70.00 in cash at closing, representing a significant premium to recent trading prices.
The board unanimously recommends shareholders vote in favor of the merger, the related executive compensation, and the potential adjournment of the special meeting if more votes are needed.
The merger is subject to customary closing conditions, including regulatory approvals, antitrust clearance, and shareholder approval by a majority of outstanding shares.
If the merger is not completed, the company will remain public, and termination fees may apply to either party under certain circumstances.
Voting matters and shareholder proposals
Shareholders are to vote on: (1) the merger agreement, (2) an advisory vote on executive compensation related to the merger, and (3) adjournment of the meeting if necessary to solicit more proxies.
Approval of the merger requires a majority of outstanding shares; abstentions and non-votes count as votes against.
The compensation proposal is advisory and not binding; the adjournment proposal is only called if needed.
Appraisal rights are available for dissenting shareholders under Delaware law.
Board of directors and corporate governance
The board conducted a comprehensive review of strategic alternatives, engaged financial and legal advisors, and ran a competitive process with multiple bidders.
The board considered the premium offered, certainty of value, and the terms of the merger agreement, including the ability to respond to superior proposals.
The board and management have interests in the merger, including accelerated vesting of equity awards and potential severance, which were disclosed and considered.
Latest events from Brighthouse Financial
- Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 202523 Feb 2026 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 202415 Jan 2026 - Shareholders to vote on $70/share cash merger with Aquarian Holdings; board recommends approval.BHF
Proxy Filing7 Jan 2026 - Q4 2024 net income was $646M, with record annuity and life sales and strong capital metrics.BHF
Q4 202426 Dec 2025 - Preliminary proxy outlines annual meeting proposals and board governance for shareholder vote.BHF
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and updated incentive plan amid strong strategic progress.BHF
Proxy Filing1 Dec 2025